Increased Cytopathic Effect of Replicating Adenovirus Expressing Adenovirus Death Protein.
- Author:
Eunhee KIM
1
;
Joo Hang KIM
;
Taeyoung KOO
;
Joo Hyuk SOHN
;
Chae Ok YUN
Author Information
1. Institute for Cancer Research, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. chaeok@yumc.yonsei.ac.kr
- Publication Type:In Vitro ; Original Article
- Keywords:
Cancer gene therapy;
Replication competent adenovirus;
Adenovirus death protein;
Apoptosis
- MeSH:
Adenosine Diphosphate;
Adenoviridae*;
Apoptosis;
Cell Line;
Genes, Neoplasm;
Heterografts;
In Situ Nick-End Labeling
- From:Cancer Research and Treatment
2003;35(5):425-432
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Replication-competent adenoviruses (Ads) are promising new modalities for the treatment of cancer. Selective replication of a viral agent in tumor may lead to improved efficacy over non-replicating Ads due to viral multiplication, lysis of the infected cancer cell and spread to surrounding cells. In our previous studies it was shown that the E1B 55 kD-deleted Ad (YKL-1) exhibits tumor specific replication and cell lysis, but with reduced cytolytic effects compared to the wild type adenovirus (Int J Cancer 2000;88: 454-463). Thus, improving the potency of oncolytic Ads remains an important goal for cancer gene therapy. To increase the oncolytic ability of YKL-1, an adenovirus death protein (ADP) gene was reintroduced under the control of a CMV or MLP promoter at the E3 region of the YKL-1, generating an YKL-cADP and YKL-mADP, respectively. MATERIALS AND METHODS: The in vitro cytolytic effect of ADP expressing Ads was evaluated by MTT assay, and the induction of apoptosis by ADP expressing Ads was examined by TUNEL analysis. Finally, the antitumor effect of ADP expressing Ads was demonstrated in C33A xenograft tumor model. RESULTS: The YKL-cADP exerted a markedly enhanced cytolytic effect against H460 and SK-Hep1 cancer cell lines. The TUNEL assay indicated that the ADP-mediated cytotoxicity was largely driven by apoptosis. Finally, the YKL-cADP showed a superior antitumor effect than the YKL-1 or YKL-mADP in C33A xenografts. CONCLUSION: These lines of evidence demonstrate that the YKL-cADP induces efficient cell lysis, which is critical for the addition of therapeutic value to replicating Ads in cancer gene therapy.
